• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TherapeuticsMD, Inc. - Common Stock (NQ:TXMD)

2.080 +0.010 (+0.48%)
Streaming Delayed Price Updated: 11:44 AM EDT, Aug 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about TherapeuticsMD, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
TherapeuticsMD Announces First Quarter 2026 Financial Results
May 12, 2026
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Announces Full Year 2025 Financial Results
March 30, 2026
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Announces Third Quarter 2025 Financial Results
November 12, 2025
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Announces Second Quarter 2025 Financial Results
August 12, 2025
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Announces First Quarter 2025 Financial Results
May 13, 2025
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Announces Full Year 2024 Financial Results
March 27, 2025
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Announces Third Quarter 2024 Financial Results
November 12, 2024
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Announces Second Quarter 2024 Financial Results
August 12, 2024
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Announces First Quarter 2024 Financial Results
May 10, 2024
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Announces Full Year 2023 Financial Results
March 29, 2024
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Announces Third Quarter 2023 Financial Results
November 14, 2023
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Announces Second Quarter 2023 Financial Results
August 14, 2023
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Announces First Quarter 2023 Financial Results
May 15, 2023
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition
April 07, 2023
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma
January 03, 2023
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
December 04, 2022
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Announces Third Quarter 2022 Financial Results
November 14, 2022
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Announces Additional $7 Million Private Placement
October 31, 2022
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Announces $7 Million Private Placement
October 03, 2022
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers
September 12, 2022
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Announces Second Quarter 2022 Financial Results
August 15, 2022
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD to Report Second Quarter 2022 Financial Results on August 15, 2022
August 08, 2022
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
August 01, 2022
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Announces Expiration of Tender Offer
July 13, 2022
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
THERAPEUTICSMD INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TherapeuticsMD, Inc. - TXMD
May 31, 2022
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
TXMD Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of TherapeuticsMD, Inc. Is Fair to Shareholders
May 31, 2022
From Halper Sadeh LLP
Via Business Wire
News headline image
TherapeuticsMD and EW Healthcare Partners Announce Definitive Agreement for EW Healthcare Partners to acquire TherapeuticsMD
May 31, 2022
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug Application (sNDA) for ANNOVERA®
May 20, 2022
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD Announces First Quarter 2022 Financial Results
May 16, 2022
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD to Report First Quarter 2022 Financial Results on May 16, 2022
May 10, 2022
From TherapeuticsMD, Inc.
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap